[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:patatin-like-phospholipase-domain-containing-protein-3":3},{"name":4,"total":5,"recruiting":5,"trials":6},"PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05648214","A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:21.315591Z","2026-05-05T02:43:26.719386Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07527910","A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD",[19],"Phase 2","2026-08-26T02:19:05.360997Z","2026-07-05T03:45:20.252831Z"]